[Immune Regulation by TNF Receptor-associated Factor 5]

Area of Science:

• Immunology
• Molecular Biology
• Cellular Signaling

Background:

• Tumor necrosis factor receptor (TNFR)-associated factors (TRAFs) are key intracellular adaptors in TNFR and Toll-like receptor signaling.
• The in vivo function of TRAF5, particularly in CD4+ T cell signaling, remains incompletely understood.
• TRAF5 is implicated as a potential regulator of TNFR superfamily members.

Purpose of the Study:

• To elucidate the in vivo function of TRAF5 in CD4+ T cell signaling.
• To investigate the role of TRAF5 in interleukin-6 (IL-6) and IL-27 receptor signaling pathways.
• To determine the impact of TRAF5 deficiency on T cell differentiation and autoimmune disease progression.

Main Methods:

• Investigated TRAF5's interaction with glycoprotein 130 (gp130), the IL-6 receptor.
• Analyzed the effect of TRAF5 deficiency on janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway activity.
• Utilized experimental autoimmune encephalomyelitis and delayed-type hypersensitivity models to assess disease outcomes in Traf5-deficient mice.

Main Results:

• TRAF5 directly binds to gp130 and inhibits JAK-STAT signaling.
• Traf5-deficient CD4+ T cells exhibit enhanced IL-6-driven differentiation into T helper 17 (Th17) cells, exacerbating neuroinflammation.
• Traf5-deficient CD4+ T cells show increased IL-27-mediated differentiation into T helper 1 (Th1) cells, worsening delayed-type hypersensitivity responses.

Conclusions:

• TRAF5 acts as a negative regulator of gp130 signaling in CD4+ T cells.
• TRAF5 critically controls CD4+ T cell differentiation into Th17 and Th1 subsets.
• Dysregulation of TRAF5 in T cells contributes to the pathogenesis of autoimmune and inflammatory diseases.